The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CVRx shares were 19% higher, at $8.48, after the company said that the Centers for Medicare and Medicaid Services has proposed keeping CVRx's Barostim implant procedure as part of the New Technology ...

CVRx Inc. CVRX announced a key reimbursement win after Humana issued a Medicare Advantage coverage policy for its Barostim therapy. The development marks an important step in expanding patient access ...

CVRx CVRX announced that Devoted Health has issued a Medicare Advantage coverage policy for its Barostim therapy, effective July 17, 2026. The policy covers patients under the current FDA-approved ...

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS) has reassigned the Barostim implant procedure for ...

COLUMBUS, Ga. (WRBL) — Healthcare professionals with Piedmont Columbus Regional performed their first Barostim procedure, improving the quality of life for a patient experiencing heart failure in ...

CVRx Inc. (NASDAQ: CVRX) announced that Category I Current Procedural Terminology codes for its Barostim baroreflex activation therapy replaced Category III codes effective January 1, 2026, according ...

CVRx's Barostim is a long-term compounder that presents with interesting economics. Clinical data is robust for the device and it continues to benefit from regulatory tailwinds. News around the device ...

MINNEAPOLIS, Nov. 03, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS) has ...

MINNEAPOLIS, July 16, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) ...

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) ...